Functions of circular RNAs generated from backsplicing of the HIV-1 primary transcript

HIV-1初级转录物反向剪接产生的环状RNA的功能

基本信息

  • 批准号:
    10481143
  • 负责人:
  • 金额:
    $ 22.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Circular RNAs (circRNAs) are a family of non-coding RNAs that originate from a non-canonical splicing event, named backsplicing, in which the upstream and downstream splicing sites of an RNA transcript become covalently linked to form a closed loop of RNA as opposed to the typical linear structure of mRNA transcripts. Cellular circRNAs play a role in development, cell differentiation, proliferation and are associated with cancer, neurological disorders, autoimmune and cardiovascular disease. circRNAs act as miRNAs sponges, thus inhibiting their function, and by interacting with RNA binding proteins (RBPs), modulating their availability, localization and activity. A few circRNAs have been also shown to modulate transcription and can be translated into short proteins. CircRNAs of viral origin have been identified in DNA viruses from the Herpesviridae and Papillomaviridae families. These viral circRNAs have been shown to promote cell proliferation and metastasis by acting as sponges for miRNAs with functions in tumor suppression. To date, no circRNA encoded by an RNA virus has been characterized. Analysis of the complex HIV-1 splicing pattern revealed that this virus has the potential to generate at least 15 distinct circRNAs. We designed several sets of divergent PCR primers to specifically amplify the predicted HIV circRNA isoforms. Divergent primers were designed to extend in opposite directions on templates from linear transcripts but extend towards each and amplify circularized transcripts. We were able to amplify and confirm by sequencing 15 distinct circRNA isoforms generated from backsplicing of the viral pre-mRNA. Given the long half-life of circRNAs (4-5 times the one of linear RNAs) it is plausible that HIV derived circRNAs modulate viral replication and infection by conditioning the infected cells. In this study we propose to define the precise amount and composition of the circular RNA molecules produced by the virus in primary T cells and a HIV latency model utilizing a combination of circRNA isoform specific qPCR and RNA Sequencing assays. We will also determine the role of the HIV-1 circRNAs in viral replication utilizing both, gain and loss of functions assays.
项目总结 环状RNA(CircRNAs)是一类起源于非规范剪接的非编码RNA 事件,称为反向剪接,在该事件中,RNA转录本的上游和下游剪接位点变成 共价连接形成RNA的闭合环,而不是典型的mRNA转录本的线性结构。 细胞CircRNA在发育、细胞分化、增殖中发挥作用,并与癌症有关, 神经疾病、自身免疫和心血管疾病。CircRNA充当miRNAs海绵,因此 抑制它们的功能,并通过与RNA结合蛋白(RBPs)相互作用,调节它们的可用性, 本地化和活跃性。一些CircRNA也被证明可以调节转录,并可以 转化成短蛋白质。已在来自中国的DNA病毒中发现了源于病毒的CircRNA 疱疹病毒科和乳头病毒科。这些病毒环状RNA已被证明能促进细胞 增殖和转移,作为具有肿瘤抑制功能的miRNAs的海绵。到目前为止, 目前还没有鉴定出由RNA病毒编码的CircRNA。 对复杂的HIV-1剪接模式的分析表明,该病毒有可能在 至少15个不同的CircRNA。我们设计了几组不同的聚合酶链式反应引物来特异性地扩增 预测的HIV CircRNA亚型。发散的引物被设计成向相反的方向延伸 模板来自线性转录本,但向每个模板延伸并放大循环转录本。我们能够 通过测序扩增和确认病毒反向剪接产生的15种不同的CircRNA异构体 前信使核糖核酸。鉴于CircRNA的半衰期很长(是线性RNA的4-5倍),有可能HIV 衍生的CircRNA通过调节受感染的细胞来调节病毒复制和感染。在这项研究中,我们 建议确定病毒产生的环状RNA分子的确切数量和组成 在原代T细胞和利用CircRNA异构体特异性qPCR和RNA组合的HIV潜伏期模型中 测序分析。我们还将利用两者来确定HIV-1 CircRNA在病毒复制中的作用, 功能得失分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MASSIMO CAPUTI其他文献

MASSIMO CAPUTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MASSIMO CAPUTI', 18)}}的其他基金

Inhibition of HIV-1 replication by delivery of the SRSF1 RNA Recognition Motifs
通过传递 SRSF1 RNA 识别基序抑制 HIV-1 复制
  • 批准号:
    8993337
  • 财政年份:
    2015
  • 资助金额:
    $ 22.88万
  • 项目类别:
hnRNP A1 inhibition of HIV-1 replication
hnRNP A1 抑制 HIV-1 复制
  • 批准号:
    8140976
  • 财政年份:
    2011
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    6989731
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    6591090
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    7151161
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    6911298
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    6688992
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of HIV-1 RNA Processing
HIV-1 RNA 加工的调控
  • 批准号:
    6828254
  • 财政年份:
    2002
  • 资助金额:
    $ 22.88万
  • 项目类别:

相似海外基金

Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
  • 批准号:
    10759950
  • 财政年份:
    2023
  • 资助金额:
    $ 22.88万
  • 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
  • 批准号:
    10677284
  • 财政年份:
    2023
  • 资助金额:
    $ 22.88万
  • 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
  • 批准号:
    10464020
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
  • 批准号:
    10484703
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
  • 批准号:
    10547347
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10806783
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10689248
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10501862
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
  • 批准号:
    10623180
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
  • 批准号:
    BB/V019848/1
  • 财政年份:
    2021
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了